Bridge to cardiac transplantation
Autor: | Carla J. Nastala |
---|---|
Rok vydání: | 1995 |
Předmět: |
Heart transplantation
medicine.medical_specialty Bridge to transplant Waiting Lists business.industry Patient Selection medicine.medical_treatment Mortality rate Critical Care Nursing Actuarial survival Exercise Therapy Transplantation surgical procedures operative Donor heart Quality of life Current practice medicine Heart Transplantation Humans Heart-Assist Devices Intensive care medicine business |
Zdroj: | Critical Care Nursing Quarterly. 18:65-76 |
ISSN: | 0887-9303 |
Popis: | Cardiac transplantation is primarily limited by the undersupply of donor organs. An estimated 20% of all heart transplant candidates will die before a donor heart becomes available. This high pretransplant mortality rate has prompted the institution of mechanical circulatory support (MCS) as a bridge to transplant for those who develop severe cardiac failure before cardiac transplantation. Actuarial survival in MCS patients after cardiac transplantation is equal to that of transplant recipients treated with more conventional therapies. These results have encouraged researchers in the field to investigate portable devices and more permanent implants. Current practice at one transplant center offers the Novacor (Baxter Healthcare), Thoratec (Thoratec Laboratories, Inc), and Cardiowest (Cardiowest Technologies, Inc) bridge-to-transplant devices. This article will discuss each device in detail. Other areas addressed include patient selection, patient management, and quality of life (QOL). |
Databáze: | OpenAIRE |
Externí odkaz: |